These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 30385739)
1. Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism. Lincoln FA; Imig D; Boccellato C; Juric V; Noonan J; Kontermann RE; Allgöwer F; Murphy BM; Rehm M Cell Death Dis; 2018 Nov; 9(11):1112. PubMed ID: 30385739 [TBL] [Abstract][Full Text] [Related]
2. IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis. Perimenis P; Galaris A; Voulgari A; Prassa M; Pintzas A BMC Cancer; 2016 Aug; 16():624. PubMed ID: 27520705 [TBL] [Abstract][Full Text] [Related]
3. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells. Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214 [TBL] [Abstract][Full Text] [Related]
4. Co-treatment of birinapant with TRAIL synergistically induces apoptosis by downregulating cFLIP(L) in MDA-MB-453 cell lines. Park EJ; Kim HD; Choi EK; Hoe KL; Kim DU Biochem Biophys Res Commun; 2020 Dec; 533(3):289-295. PubMed ID: 32958259 [TBL] [Abstract][Full Text] [Related]
5. ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells. Cristofanon S; Fulda S Cell Death Dis; 2012 Nov; 3(11):e432. PubMed ID: 23190604 [TBL] [Abstract][Full Text] [Related]
6. Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism. Vetma V; Guttà C; Peters N; Praetorius C; Hutt M; Seifert O; Meier F; Kontermann R; Kulms D; Rehm M Cell Death Differ; 2020 Aug; 27(8):2417-2432. PubMed ID: 32081986 [TBL] [Abstract][Full Text] [Related]
7. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism. Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169 [TBL] [Abstract][Full Text] [Related]
8. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma. Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353 [TBL] [Abstract][Full Text] [Related]
9. Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant. Zakaria Z; Tivnan A; Flanagan L; Murray DW; Salvucci M; Stringer BW; Day BW; Boyd AW; Kögel D; Rehm M; O'Brien DF; Byrne AT; Prehn JH Br J Cancer; 2016 Jan; 114(2):188-98. PubMed ID: 26657652 [TBL] [Abstract][Full Text] [Related]
10. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production. Kim WS; Lee KS; Kim JH; Kim CK; Lee G; Choe J; Won MH; Kim TH; Jeoung D; Lee H; Kim JY; Ae Jeong M; Ha KS; Kwon YG; Kim YM Free Radic Biol Med; 2017 Nov; 112():567-577. PubMed ID: 28888620 [TBL] [Abstract][Full Text] [Related]
11. RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex. Abhari BA; Cristofanon S; Kappler R; von Schweinitz D; Humphreys R; Fulda S Oncogene; 2013 Jul; 32(27):3263-73. PubMed ID: 22890322 [TBL] [Abstract][Full Text] [Related]
12. Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway. Premkumar DR; Jane EP; Foster KA; Pollack IF J Pharmacol Exp Ther; 2013 Aug; 346(2):201-10. PubMed ID: 23740602 [TBL] [Abstract][Full Text] [Related]
13. Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis. Unterkircher T; Cristofanon S; Vellanki SH; Nonnenmacher L; Karpel-Massler G; Wirtz CR; Debatin KM; Fulda S Clin Cancer Res; 2011 Jun; 17(12):4019-30. PubMed ID: 21525171 [TBL] [Abstract][Full Text] [Related]
14. TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1. Son JK; Varadarajan S; Bratton SB Cell Death Differ; 2010 Aug; 17(8):1288-301. PubMed ID: 20168333 [TBL] [Abstract][Full Text] [Related]
15. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496 [TBL] [Abstract][Full Text] [Related]
16. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. Hari Y; Harashima N; Tajima Y; Harada M Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422 [TBL] [Abstract][Full Text] [Related]
17. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R; Bedi A Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014 [TBL] [Abstract][Full Text] [Related]
18. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation. Rosato RR; Almenara JA; Coe S; Grant S Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059 [TBL] [Abstract][Full Text] [Related]
19. Cleavage by Caspase 8 and Mitochondrial Membrane Association Activate the BH3-only Protein Bid during TRAIL-induced Apoptosis. Huang K; Zhang J; O'Neill KL; Gurumurthy CB; Quadros RM; Tu Y; Luo X J Biol Chem; 2016 May; 291(22):11843-51. PubMed ID: 27053107 [TBL] [Abstract][Full Text] [Related]
20. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells. Petak I; Vernes R; Szucs KS; Anozie M; Izeradjene K; Douglas L; Tillman DM; Phillips DC; Houghton JA Cell Death Differ; 2003 Jun; 10(6):729-39. PubMed ID: 12761581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]